Evidence map›Paper›PMID 34199575›Full record

ReviewNutrients2021

Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy.

Yanan Wang, Qing Liu, Helong Quan, Seong-Gook Kang, Kunlun Huang, Tao Tong

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Wearable Bioelectronics for Home-Based Monitoring and Treatment of Muscle Atrophy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yanan WangBeijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.ORCID 0000-0002-1730-3804
Qing LiuJilin Green Food Engineering Research Institute, Changchun 130022, China.
Helong QuanExercise and Metabolism Research Center, College of Physical Education and Health Sciences, Zhejiang Normal University, 688 Yingbin Avenue, Jinhua 321004, China.
Seong-Gook KangDepartment of Food Engineering, Mokpo National University, Muangun 58554, Korea.ORCID 0000-0002-8498-120X
Kunlun HuangBeijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Tao TongBeijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.ORCID 0000-0002-9309-2893
China Agricultural University · CNMokpo National University · KRZhejiang Normal University · CN

Funding

Kunlun Huang The National Key R&D Program of China (grant number: 2017YFC1600901)Yunbo Luo The 2115 Talent Development Program of China Agricultural University
6 · The paper itself

Abstract

Imbalance of protein homeostasis, with excessive protein degradation compared with protein synthesis, leads to the development of muscle atrophy resulting in a decrease in muscle mass and consequent muscle weakness and disability. Potential triggers of muscle atrophy include inflammation, malnutrition, aging, cancer, and an unhealthy lifestyle such as sedentariness and high fat diet. Nutraceuticals with preventive and therapeutic effects against muscle atrophy have recently received increasing attention since they are potentially more suitable for long-term use. The implementation of nutraceutical intervention might aid in the development and design of precision medicine strategies to reduce the burden of muscle atrophy. In this review, we will summarize the current knowledge on the importance of nutraceuticals in the prevention of skeletal muscle mass loss and recovery of muscle function. We also highlight the cellular and molecular mechanisms of these nutraceuticals and their possible pharmacological use, which is of great importance for the prevention and treatment of muscle atrophy.

Indexed as

Dietary SupplementsAmino AcidsAnimalsDatabases, FactualFatty AcidsHumansInflammationMineralsMuscle, SkeletalMuscular AtrophyPeptidesPhytochemicalsProbioticsProteinsProteolysisVitaminsAmino AcidsFatty AcidsMineralsPeptidesPhytochemicalsProteinsVitaminsmolecular mechanismsmuscle atrophynutraceuticalphytochemicalprotein synthesis/degradation

Identifiers

PMID34199575
PMCPMC8227811
OpenAlexW3170817666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.